I am currently working on the impurity profile to address degradation products (literature based impurities) and method capability of drug product as well as prepared a scientific report for degradation products to file ANDA submission.
In addition, risk assessment of the nitrosamine (simple as well NDSRIs) in drug product based on the chemistry aspect, literatures and guidelines.